For a 66-year-old man with elevated follicle‑stimulating hormone (FSH) 27.2 IU/L, normal luteinizing hormone (LH) 7.2 IU/L, total testosterone 549 ng/dL, free testosterone 111 pg/mL, and sex hormone‑binding globulin (SHBG) 37 nmol/L, what is the recommended management regarding scrotal ultrasound, urology referral, and treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Elevated FSH with Normal Testosterone in a 66-Year-Old Man

This 66-year-old man has primary testicular dysfunction (compensated hypospermatogenesis) indicated by markedly elevated FSH (27.2 IU/L) despite normal total and free testosterone levels, and requires scrotal ultrasound to evaluate testicular pathology, assess for varicocele, and screen for testicular malignancy, followed by urology referral for comprehensive fertility evaluation and surveillance.

Understanding the Hormonal Pattern

Your FSH of 27.2 IU/L is significantly elevated—nearly 4 times the upper threshold of 7.6 IU/L used to distinguish obstructive from non-obstructive causes of impaired spermatogenesis 1. This elevation indicates primary testicular dysfunction where the pituitary is attempting to compensate for failing testicular function by increasing FSH output 1, 2.

The relatively normal LH (7.2 IU/L) and preserved testosterone levels (total 549 ng/dL, free 111 pg/mL) suggest that:

  • Leydig cell function (testosterone production) remains relatively intact
  • Sertoli cell function (spermatogenesis) is significantly impaired
  • The hypothalamic-pituitary-testicular axis is attempting compensation 3

This pattern is termed "compensated hypospermatogenesis"—where FSH elevation precedes testosterone decline as an early marker of testicular dysfunction 4.

Why Scrotal Ultrasound Is Indicated

Scrotal ultrasound is specifically recommended in this clinical scenario for multiple critical reasons 2:

Testicular volume assessment: FSH >7.6 IU/L with testicular atrophy suggests non-obstructive azoospermia or severe oligospermia 1. Physical examination may underestimate volume, and ultrasound provides precise measurements.

Structural abnormalities detection: Look for non-homogeneous testicular architecture and microcalcifications, which indicate testicular dysgenesis associated with impaired spermatogenesis 2.

Varicocele evaluation: Men with varicocele demonstrate significantly elevated FSH (mean difference 2.18 IU/L higher than controls) and reduced testicular volume bilaterally 3. Your FSH elevation warrants assessment for this treatable cause.

Cancer screening: Infertile men have 1.91 times higher risk of testicular cancer compared to fertile men 2. Men with oligospermia have an 11.9-fold higher cancer risk 2. The combination of elevated FSH and potential oligospermia places you in a higher-risk category requiring surveillance.

Obstruction assessment: Ultrasound can identify dilated rete testis, enlarged epididymis with cystic lesions, or absent vas deferens—indirect signs of obstruction 2.

Why Urology Referral Is Necessary

Urology referral is warranted based on current guidelines 1, 2:

Genetic testing indications: With FSH of 27.2 IU/L, if semen analysis reveals sperm concentration <5 million/mL, you require:

  • Karyotype testing (4% risk of chromosomal abnormalities with counts <5 million/mL) 2
  • Y-chromosome microdeletion testing (5% prevalence in severely oligospermic men) 1

Fertility preservation: At age 66, if fertility is a concern, evaluation for sperm retrieval options or banking should occur before further testicular function decline 4.

Longitudinal monitoring: Men with elevated FSH and initially normal semen parameters experience progressive decline in sperm concentration and total motile sperm count over time 4. You require serial semen analyses every 6-12 months to track progression.

Treatment consideration: If varicocele is identified, surgical correction may improve hormonal parameters and semen quality 3.

Clinical Trajectory and Prognosis

Research demonstrates that men with elevated FSH (≥7.6 IU/L) and normal baseline semen analysis are significantly more likely to develop:

  • Oligospermia (<15 million/mL) over time
  • Total motile sperm count <9 million (below intrauterine insemination threshold)
  • Progressive accumulation of semen abnormalities 4

At age 66, your testosterone levels remain adequate (total 549 ng/dL, free 111 pg/mL), but longitudinal studies show gradual testosterone decline continues through the 8th-10th decades 5. Among men with initially normal testosterone, 20.5% develop levels <275 ng/dL over 14 years 5.

Common Pitfalls to Avoid

Do not dismiss elevated FSH because testosterone is normal: The free hormone hypothesis and your elevated gonadotropins provide independent evidence of primary testicular insufficiency, even with preserved testosterone 6. FSH elevation precedes testosterone decline.

Do not delay imaging: The cancer risk and potential for treatable pathology (varicocele) necessitate prompt ultrasound evaluation 2.

Do not assume stable function: Your FSH of 27.2 IU/L predicts progressive decline in testicular function requiring surveillance 4.

Immediate Action Steps

  1. Order scrotal ultrasound with specific attention to testicular volume, architecture, microcalcifications, varicocele, and masses
  2. Refer to urology for comprehensive male reproductive health evaluation
  3. Obtain baseline semen analysis if not already done—this determines need for genetic testing 1, 2
  4. Schedule follow-up hormonal assessment in 6-12 months to track FSH trajectory and testosterone stability
  5. Document symptoms of hypogonadism (libido, erectile function, energy, mood) for longitudinal comparison

Your SHBG of 37 nmol/L is normal, so the free testosterone calculation is reliable and confirms adequate bioavailable testosterone currently 6.

References

5
Research

Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men.

The Journal of clinical endocrinology and metabolism, 2026

Related Questions

What is the likely diagnosis and recommended next steps for a patient with elevated follicle‑stimulating hormone (FSH), normal luteinizing hormone (LH), normal total testosterone, normal free testosterone, and normal sex hormone‑binding globulin (SHBG)?
What are the health risks associated with elevated follicle‑stimulating hormone (FSH) and luteinising hormone (LH) in men?
Interpret the laboratory results (follicle‑stimulating hormone 40.6 IU/L, luteinizing hormone 27.5 IU/L, testosterone 14 ng/dL, estradiol 47.5 pg/mL, progesterone 0.3 ng/mL, sex hormone‑binding globulin 64.4 nmol/L) in a 46‑year‑old female with a partial hysterectomy.
In a 66-year-old man with isolated elevated follicle‑stimulating hormone, normal luteinizing hormone, testosterone, and sex hormone‑binding globulin, and not receiving testosterone replacement therapy, should he undergo scrotal ultrasound and be referred to urology for further evaluation?
How should the laboratory results (elevated luteinizing hormone (LH), elevated follicle‑stimulating hormone (FSH), low estradiol, low progesterone, and sex hormone‑binding globulin (SHBG) in the high‑normal range) be interpreted in a 46‑year‑old female with a history of uterine ablation?
What does a feeling of pressure or fullness in the head before or after a migraine indicate, and how should it be treated?
I have streptococcal pharyngitis and began amoxicillin three days ago; I developed an itchy red rash yesterday that has worsened today—what should I do?
What does a normal complement component 3 (C3) level and a low complement component 4 (C4) level indicate in patients with systemic lupus erythematosus?
What is an objective management plan for a patient with severe pain after femoral catheterization when vascular surgery is not available at the facility?
What is the correlation between estradiol and testosterone?
What is the expected postoperative facial nerve function and recommended assessment schedule after facial nerve translocation in adults without pre‑existing facial nerve disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.